Does Medicare Cover Peripheral Nerve Stimulators?
Medicare coverage for peripheral nerve stimulation depends on the specific device and service, clinical circumstances, and the beneficiary's coverage. CMS says payment may be made under the prosthetic-device benefit for an implanted peripheral nerve stimulator. But that statement does not guarantee approval or payment for a particular procedure or claim. An evaluation or trial may also be treated differently from a later implant.
So, does Medicare cover peripheral nerve stimulators? CMS states that payment may be made for implanted peripheral nerve stimulators under the prosthetic-device benefit, but an individual decision depends on applicable policy, plan, and claim details. CMS's National Coverage Determination describes that limited statement, not blanket approval for every device or patient.
Knowing what the national policy says and what it leaves to local or plan review can help you prepare useful questions for your care team and coverage provider.
Does Medicare cover peripheral nerve stimulators?
Sometimes, but the answer depends on what kind of peripheral nerve stimulation is being considered and how the service is reviewed. CMS's national coverage determination (NCD), a Medicare policy that applies nationally, says payment may be made under the prosthetic device benefit for an implanted peripheral nerve stimulator. That is not a guarantee that a particular patient's device, procedure, or claim will be covered or paid.
The NCD describes an implanted system as electrodes placed around a selected peripheral nerve and connected to a receiver implanted under the skin. The policy notes that electrode implantation involves surgery. This description is specific to implanted peripheral nerve stimulation. It should not be read as a coverage statement for every external or transcutaneous stimulation product, or as a decision about a particular claim. CMS also distinguishes peripheral nerve stimulators from central nervous system stimulators, such as devices used for spinal stimulation. Read CMS's National Coverage Determination 160.7 for the policy's exact scope.
There can also be a difference between using stimulation to assess whether someone may be suitable for ongoing treatment and coverage for an implanted device as a prosthesis. CMS explains that a peripheral nerve stimulator used for suitability assessment is covered as part of the diagnostic service, rather than as a prosthesis. These statements describe policy categories; they do not establish that every trial or related service is covered in every circumstance.
Coverage review and clinical suitability are separate questions. A clinician considers whether a treatment fits an individual's condition and circumstances. Medicare or the relevant Medicare plan reviews coverage under applicable policy and plan terms, including the exact service and claim details. For general information about the procedure itself, see ReleviiMed's peripheral nerve stimulation treatment page. It is educational, not a coverage determination or individualized medical advice. Before proceeding, patients can confirm the specific device and service with their plan and care team.
What CMS policy says about implanted PNS
CMS national coverage determination (NCD) 160.7 addresses electrical nerve stimulators. For implanted peripheral nerve stimulators, it says payment may be made under the prosthetic-device benefit. That wording is important: it identifies a possible Medicare benefit category, but it is not a promise that a particular person, device, procedure, or claim will be covered. The NCD also notes that its listed benefit category may not include every category that could apply. Read CMS NCD 160.7.
The NCD describes implanted PNS as electrodes placed around a selected peripheral nerve and connected to a receiver implanted under the skin. It separately discusses central nervous system stimulation, including spinal cord stimulation, so the two should not be treated as interchangeable. Nor does the implanted-device language automatically settle coverage for every external or skin-surface stimulator. Device type and the service being considered matter.
CMS also has a separate NCD, 160.7.1, about assessing a patient's suitability for ongoing electrical nerve stimulation. It addresses diagnostic approaches, including stimulation used to evaluate whether continued treatment may be useful. CMS says this assessment is part of a diagnostic service rather than the prosthetic benefit for an implanted stimulator. In other words, a trial or evaluation and a later implantation are distinct parts of the policy discussion, not one blanket coverage decision. See CMS NCD 160.7.1.
An NCD is national policy. A local coverage determination (LCD), by contrast, is issued by a Medicare Administrative Contractor (MAC) for its assigned jurisdiction. It may address local coverage questions not resolved by an NCD, so an LCD from one contractor or region should not be assumed to govern every beneficiary. The CMS Medicare Coverage Database lists the relevant contractor and jurisdiction on an LCD record.
Currentness matters. CMS marks its Peripheral Nerve Stimulation LCD L37360 as retired, with a retirement date of October 23, 2025. That record is historical, not a current universal checklist. Do not rely on old LCD criteria as though they automatically apply today. Before proceeding, check the Medicare Coverage Database for current policy relevant to the beneficiary's location and the exact service being considered. And confirm details with the plan or payer. A policy page is useful context, but an individual coverage or claim decision depends on the specific circumstances. View the CMS L37360 record and status.
Why device details and medical records matter
A coverage question is easier to check when it describes the proposed service precisely. "A nerve stimulator" can refer to different technologies and care pathways. The federal Medicare policy for implanted electrical nerve stimulators describes an implanted device with electrodes placed through surgery. It does not make every external stimulator, diagnostic procedure, or implant interchangeable. You can read more about how peripheral nerve stimulation works, then ask your care team which specific approach is being considered. CMS's national coverage determination provides the policy context for implanted devices, but it is not an advance promise that a particular claim will be paid.
When you contact a plan or review a coverage response, useful questions may include:
What device and procedure are being proposed, and is the stimulation external, percutaneous, or implanted?
What diagnosis and symptoms are documented, and why does the clinician recommend this option for your situation?
Which provider and facility would furnish the service, and what records or plan review are needed before proceeding?
If a stimulation trial or another evaluation is part of the plan, what is its purpose, and how will the clinical team document its findings?
These are practical questions, not a universal Medicare checklist or a guarantee of coverage. CMS policy discusses documentation in specific circumstances, including medical necessity for certain diagnostic services, but applicable requirements depend on the service and current policy. A Blue Cross Blue Shield of North Carolina policy, for example, may illustrate how one insurer describes its own review. It should not be read as a rule for Original Medicare or every Medicare Advantage plan.
Medical records can help explain the clinical context: the diagnosis, relevant treatment history, the proposed device and service, and the clinician's reasoning. They support an informed review but do not determine the payer's decision by themselves. A clinician evaluates whether a treatment is medically appropriate for an individual; the plan or payer applies its coverage terms and decides whether a service or claim qualifies. For Medicare Advantage members, Medicare describes a right to request an organization determination about whether a service is covered. Ask the plan what information it needs and request its decision in writing when appropriate: Medicare's guidance on plan coverage decisions.
How Original Medicare and Medicare Advantage differ
Both coverage paths share an important baseline: Medicare Advantage plans must cover medically necessary services that Original Medicare covers. That baseline does not mean every peripheral nerve stimulator request is automatically covered or approved. The specific device, service, medical record, and claim still matter, and each plan may apply different procedures for reviewing care.
Coverage question | Original Medicare | Medicare Advantage |
Medical-necessity baseline | Covers most medically necessary services and supplies in health care settings. CMS says payment may be made under the prosthetic-device benefit for implanted peripheral nerve stimulators, but this is not a guarantee that a particular claim will be paid. | Must cover medically necessary services covered by Original Medicare. Plan-specific review still applies; this baseline is not automatic approval of a PNS device or procedure. |
Doctors and facilities | You can generally use any doctor or hospital that takes Medicare anywhere in the United States. Confirm that the provider accepts Medicare for the service in question. | You may need to use providers in the plan's network and service area for non-emergency care. Some plans cover certain out-of-network care under their rules. |
Referrals and plan rules | In most cases, you do not need a referral to see a specialist. Medicare coverage and claim requirements still apply. | Rules depend on the plan. You may need a referral to see a specialist, and the plan may have other service procedures to follow. |
These are general differences, not a decision about an individual PNS request. The shared medical-necessity baseline is a coverage floor, not confirmation that a particular device, procedure, or claim meets applicable requirements. Medicare Advantage plans must provide at least the same coverage as Original Medicare, but may have different rules for how members access services. Check current plan documents and ask about the exact proposed device and service, treating provider, and any referral or review requirements before proceeding. A clinician can explain why treatment is being considered; the plan or payer determines how benefits and claim rules apply.
For another example of how coverage questions can be procedure-specific, see this Medicare coverage explainer for radiofrequency ablation. It is a separate procedure, so its coverage details should not be assumed to apply to PNS.
Sources: Medicare's comparison of Original Medicare and Medicare Advantage; CMS National Coverage Determination for electrical nerve stimulators.
How to check coverage before you move forward
Before scheduling peripheral nerve stimulation, confirm details with your plan and care team. A benefits check can clarify plan rules, but it does not guarantee payment for a later claim. The exact device, service, diagnosis, setting, records, and plan terms may matter. This guide to types of peripheral nerve stimulators can help you identify what to ask about.
- Identify your exact coverage.
Check whether you have Original Medicare or a Medicare Advantage plan, and have your current plan card and relevant plan documents available. If you have Medicare Advantage, review the Evidence of Coverage and use the plan's member-services contact for current instructions.
Describe the proposed service precisely.
Ask about the specific peripheral nerve stimulator device and the proposed service, such as an evaluation, a temporary trial, or implantation, using the diagnosis your clinician is evaluating. Do not assume that a decision about one device or stage applies to another. CMS distinguishes assessment services from therapeutic use as a prosthesis in its
National Coverage Determination for electrical nerve stimulators
.
- Check the provider and setting.
Confirm whether the clinician, facility, and any other billing entity involved participate in Medicare or are in your plan's network, as applicable. Ask whether the proposed place of service is covered and whether you need a referral. Medicare Advantage plans may have network and referral rules that differ by plan; ask about each provider involved.
- Ask about advance review.
Ask whether this specific service requires prior authorization or another written review before it is performed. It is not required in every situation. If review is needed, ask who submits the request, what must be approved, and how long the plan expects the review to take.
- Find out what documentation and costs to expect.
Ask the provider what records support the request, such as the diagnosis, proposed device or procedure, and clinical rationale. Ask the plan what deductibles, copayments, coinsurance, or other costs may apply and whether these vary by provider or setting. A general estimate is not a final claim decision.
Request and keep the decision in writing.
Save the plan's response, reference number, and any conditions or limits. Medicare Advantage members can request an organization determination and have appeal rights; see
Medicare's guidance on Medicare health plan appeals
.
If the answer is no, ask what comes next.
Request the specific reason, the policy or records considered, and the deadline and instructions for an appeal. Ask your provider whether additional documentation may help. Medicare explains that appeal steps vary by coverage type in its
.
Frequently Asked Questions
Does Original Medicare or Medicare Advantage cover implanted peripheral nerve stimulation?
CMS says payment may be made under the prosthetic-device benefit for implanted peripheral nerve stimulators. But that is not a promise that a particular service or claim will be approved. Medicare Advantage plans must cover medically necessary services covered by Original Medicare, while network, referral, and plan rules can differ. Confirm the exact device, service, and circumstances with your coverage provider. CMS coverage determination; Medicare plan comparison.
What should I ask my plan before proceeding?
Ask whether the specific implanted device and proposed service are covered. Check whether a referral or prior review is required. If you have Medicare Advantage, confirm that the clinicians and facility are in network. Request a written coverage decision when available, and ask what records or service details the plan needs. A benefits check is useful, but it is not a guarantee of payment for a later claim.
Does a successful trial guarantee approval for a permanent implant?
No. CMS describes stimulation trials as a way to assess suitability, and distinguishes that diagnostic use from therapeutic use of an implanted device. A trial result does not by itself decide whether a permanent implant is clinically appropriate or covered. The treating clinician assesses the medical situation, and the payer makes its coverage or claim decision. CMS explains the distinction.
What can I do if the plan denies coverage?
Read the denial notice for the reason and the appeal deadline, then follow the instructions for your type of Medicare coverage. You can challenge a refusal to cover or pay for a service, and the appeal process varies by coverage type. Ask your provider or supplier whether records or other information may help support the appeal. Medicare appeal guidance.
Contact us to discuss peripheral nerve stimulation
If you have questions about peripheral nerve stimulation, the care team can discuss possible clinical next steps and what information may be useful. You can also ask which questions to raise about the proposed device or procedure and your plan's review process. Whether treatment is appropriate depends on an individual clinical evaluation, and the payer makes coverage decisions under the applicable plan and policy.
